Adjuvant Docetaxel for Node-Positive Breast Cancer
Work
Year: 2005
Type: article
Abstract: We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer.
Source: New England Journal of Medicine
Authors Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, Marek Pawlicki, Jean‐Paul Guastalla +27 more
Institutions Hospital Clínico San Carlos, The Maria Sklodowska-Curie National Research Institute of Oncology, Centre Léon Bérard, Response Technologies (United States), Ottawa Regional Cancer Foundation +19 more
Cites: 29
Cited by: 953
Related to: 10
FWCI: 42.39
Citation percentile (by year/subfield): 95.79
Subfield: Cancer Research
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze